AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships ...
Summary by Enid News & Eagle
1 Articles
1 Articles
All
Left
1
Center
Right
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships ...
OCALA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the recent U.S.-Poland Science and Technology Symposium 2025, held…
Coverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium